1. Lyrica EPAR Product Information by European Medicines Agency, 〈http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000546/WC500046602.pdf, 2009〉 (accessed 3 October 2013).
2. FDA Highlights of prescribing information, 〈http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022488-s004-0211446s025lbl.pdf, 2011〉 (accessed 3 October 2013).
3. FDA News release 21 June 2007, 〈http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108936.htm., 2007〉 (accessed 3 October 2013).
4. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin;Taylor;Epilepsy Res.,1993
5. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication;May;Ther. Drug Monit.,2007